Treatment
Medical therapy alone clinical trials
We’re tracking 83 recruiting studies that include Medical therapy alone, each written for real people, not researchers, below.
Recruiting studies
- NCT04453826RecruitingPhase 3
Test PD-1 plus chemo-radiation for high-risk nasopharyngeal cancer
This Phase 3 trial tests whether adding a PD-1 immunotherapy (given with chemotherapy and radiation, and also after) can improve outcomes for people with high-risk nasopharyngeal cancer. It may help by strengthening the immune system’s attack on the cancer alongside standard treatment.
Guangzhou, GuangdongAges 18–70 - NCT05862064RecruitingPhase 3
Adding an immune drug and anti-blood-vessel treatment to chemo
This study tests whether adding an immune therapy (a PD-1 antibody) plus a blood-vessel–blocking treatment to standard chemo improves outcomes for people with surgically treated triple-negative breast cancer. Everyone gets chemotherapy, but some will also get the added drugs to try to reduce cancer coming back.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT02621021RecruitingPhase 2
Metastatic melanoma trial using immune cells plus IL-2
This Phase 2 study tests a form of immune cell therapy for metastatic melanoma, using tumor-infiltrating lymphocytes (TIL) and IL-2. Some people also may receive pembrolizumab, and the goal is to see if this approach can shrink the cancer.
Bethesda, MarylandAges 18–72 - NCT07677007Recruiting
Sinus lift with bone graft materials for dental implants
This study compares two ways to build up bone in the upper jaw for dental implants. You may qualify if you need a sinus lift and have healthy gums and overall health.
Ajman, Ajman EmirateAges 21–70 - NCT05345587Recruiting
Digital monitoring plus proactive medication review during oral cancer treatment
This trial tests whether combining regular medication safety checks with electronic tracking of side effects can improve quality of life and help reduce economic burden for people taking cancer pills. It’s for people starting oral cancer therapy and using connected technology to report symptoms.
Brive-la-GaillardeAges 18 years+ - NCT06473259Recruiting
Comparing treatments for hormone-sensitive metastatic prostate cancer
This trial looks at combining hormone therapy with either chemotherapy (docetaxel), a targeted pill (like abiraterone or enzalutamide), or radiation to the prostate tumor for men whose prostate cancer has spread but is still sensitive to hormones. The goal is to see which approach works best for controlling the cancer.
Orbassano, TorinoAges Any age - NCT05990192RecruitingPhase 2
SBRT with or without niraparib for ovarian cancer after PARP inhibitor treatment
This trial tests a new treatment approach for people with ovarian cancer that has started to progress in a few spots (up to 3) after taking a PARP inhibitor. It combines targeted radiation (SBRT) to those spots, followed by another PARP inhibitor (niraparib), to see if this can control the cancer further.
Leeds, LeedsAges 18 years+ - NCT05686434RecruitingPhase 2
Osimertinib after surgery for early-stage EGFR-mutated lung cancer
This trial tests osimertinib (a targeted pill) given after surgery to help prevent early-stage lung cancer from coming back. It’s for people with fully removed, high-risk stage I non-small cell lung cancer that has specific EGFR gene changes.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07285785RecruitingPhase 4
Rifaximin plus fluids versus fluids alone for kids with acute diarrhea
This trial compares a medicine called rifaximin (given with extra fluids) to just giving extra fluids to children ages 6 to 11 with diarrhea caused by bacteria. The goal is to see if adding rifaximin helps children get better faster.
Hialeah, FloridaAges 6–12 - NCT01917552RecruitingPhase 3
Capecitabine pill treatment after stomach cancer surgery
This study compares taking capecitabine pills after curative surgery versus no further treatment. It aims to lower the chance of stomach cancer coming back in people with stage IB disease that has extra risk factors.
Seoul, Songpa-guAges 18–74 - NCT04009265RecruitingPhase 3
Compare chemotherapy, chemoradiation, or surgery alone after esophageal surgery
This Phase 3 trial looks at the best next step after surgery for thoracic esophageal squamous cell cancer that has spread to nearby lymph nodes. It compares adding chemotherapy, adding chemoradiation (chemotherapy plus radiation), or not adding additional treatment right away, to see which approach works best and is safest.
Fuzhou, FujianAges 18–75 - NCT06829797RecruitingPhase 2
Iparomlimab and chemotherapy vs chemotherapy alone for stomach cancer
This trial tests whether adding an immunotherapy drug (Iparomlimab and Tuvonralimab, combined as QL1706) to standard chemotherapy before surgery works better than chemotherapy alone for people with locally advanced stomach or gastroesophageal junction cancer that can be surgically removed.
Jinan, ShandongAges 18–75 - NCT07231458RecruitingPhase 1
Testing a new immunotherapy with pembrolizumab for advanced solid tumors
This trial tests ABX-001, a new immunotherapy, alone or with pembrolizumab, for people with advanced solid tumors that have not responded to or cannot tolerate standard treatments. It may help if your tumor has become resistant to previous immunotherapies.
BerlinAges 18 years+ - NCT06509893RecruitingPhase 4
Ticagrelor alone after stent placement
This study tests if a single blood thinner (ticagrelor) works well enough after getting a heart stent, instead of the usual two blood thinners. It may simplify your daily medication routine.
Shiraz, FarsAges 20–80 - NCT05819229Recruiting
Antibiotics by mouth only for young babies with urine infection
This trial studies whether giving antibiotics by mouth alone is enough to treat a urinary tract infection (UTI) in very young babies. It may help reduce the need for stronger or more invasive antibiotic approaches if you meet the study’s stability and urine-test requirements.
CopenhagenAges 4 weeks–2 months - NCT05933395RecruitingPhase 2
Targeted treatment for ER+ breast cancer after CDK4/6 therapy
This Phase 2 study tests a genetically guided treatment plan for ER-positive breast cancer that has progressed after CDK4/6 therapy. It may help by matching treatment to tumor genetic changes.
Lebanon, New HampshireAges 18 years+ - NCT06555003RecruitingPhase 3
DEBIRI plus chemo vs. chemo alone for liver metastases
This trial tests if a treatment called DEBIRI (tiny beads delivering chemo directly to the liver) plus standard chemotherapy works better than chemotherapy alone for colorectal cancer that has spread to the liver and can't be fully removed by surgery.
Tehran, Tehran ProvinceAges 18 years+ - NCT06828380RecruitingPhase 2
Immunotherapy with or without radiation for liver cancer
This trial tests whether using immunotherapy alone works as well as immunotherapy combined with radiation for liver cancer that has spread into major blood vessels. The goal is to find the best treatment option for people with this specific type of advanced liver cancer.
GoyangAges 19 years+ - NCT05469022RecruitingPhase 2
Lazertinib before lung surgery for EGFR-mutant lung cancer
This trial tests whether taking lazertinib before surgery can shrink or control EGFR-mutant lung adenocarcinoma that can be fully removed by an operation. It uses a special liquid biopsy from fluid in the lungs to confirm the EGFR mutation and guide treatment.
SeoulAges 19 years+ - NCT07013682Recruiting
Platelet-rich fibrin combined with deep cleaning for gum disease
This trial tests if adding platelet-rich fibrin (a natural healing concentrate from your blood) to standard deep cleaning improves treatment for advanced gum disease. It may help patients with widespread gum disease who have not had treatment in the last year.
BernAges 18 years+ - NCT07385313RecruitingPhase 4
Sheep Tissue and Vacuum Therapy for Deep Wound Healing
This trial tests a combination of a special sheep-derived material (OFM) and a vacuum dressing to help rebuild deep wounds with exposed bone or tendon. It aims to speed up healing in arm or leg injuries.
Aurora, ColoradoAges 18 years+ - NCT06300138Recruiting
Antifungal and heat therapy for sporotrichosis
This study is testing two treatments—antifungal medicine and a special heat lamp (infrared)—separately or together for sporotrichosis, a skin fungus. The goal is to find what works best with fewer side effects.
ShenyangAges Any age - NCT06974370RecruitingPhase 2
Avoiding brain radiation when chemo or other drugs work
This trial tests whether some people with brain metastases from solid tumors can safely skip radiation if their cancer drugs (like targeted therapy, immunotherapy, or certain chemotherapies) shrink the brain tumors. You will get MRI scans to see if the drugs are working.
Burlington, VermontAges 18 years+ - NCT06485271Recruiting
Camrelizumab for advanced gastric cancer
This trial tests a drug called camrelizumab, alone or with other treatments, for people with advanced stomach cancer that has worsened or returned. It aims to see how well this treatment works in real-world patients.
Changzhi, ShanxiAges 18–75
Common questions
- Are there clinical trials studying Medical therapy alone?
- Yes. Clin2 currently lists 83 recruiting studies that include Medical therapy alone, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medical therapy alone trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medical therapy alone an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medical therapy alone or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.